26.56
price down icon1.37%   -0.37
after-market Handel nachbörslich: 26.58 0.02 +0.08%
loading
Schlusskurs vom Vortag:
$26.93
Offen:
$26.345
24-Stunden-Volumen:
30.65M
Relative Volume:
2.87
Marktkapitalisierung:
$10.27B
Einnahmen:
$3.14B
Nettoeinkommen (Verlust:
$-3.36B
KGV:
-3.0424
EPS:
-8.73
Netto-Cashflow:
$-4.03B
1W Leistung:
+1.14%
1M Leistung:
-4.53%
6M Leistung:
-38.32%
1J Leistung:
-82.47%
1-Tages-Spanne:
Value
$25.60
$26.81
1-Wochen-Bereich:
Value
$25.60
$27.85
52-Wochen-Spanne:
Value
$23.15
$158.82

Moderna Inc Stock (MRNA) Company Profile

Name
Firmenname
Moderna Inc
Name
Telefon
(617) 714-6500
Name
Adresse
325 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
5,800
Name
Twitter
@moderna_tx
Name
Nächster Verdiensttermin
2025-02-14
Name
Neueste SEC-Einreichungen
Name
MRNA's Discussions on Twitter

Vergleichen Sie MRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRNA
Moderna Inc
26.56 10.16B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Citigroup Neutral
2025-02-18 Herabstufung Barclays Overweight → Equal Weight
2025-01-29 Herabstufung Goldman Buy → Neutral
2024-12-18 Herabstufung Argus Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-19 Eingeleitet Berenberg Hold
2024-11-18 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Underperform
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-09-13 Herabstufung JP Morgan Neutral → Underweight
2024-09-13 Herabstufung Jefferies Buy → Hold
2024-09-13 Herabstufung Oppenheimer Outperform → Perform
2024-08-28 Hochstufung HSBC Securities Reduce → Hold
2024-08-07 Hochstufung Deutsche Bank Sell → Hold
2024-08-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Herabstufung HSBC Securities Hold → Reduce
2024-01-02 Hochstufung Oppenheimer Perform → Outperform
2023-11-29 Eingeleitet Canaccord Genuity Hold
2023-11-03 Hochstufung HSBC Securities Reduce → Hold
2023-11-02 Herabstufung Deutsche Bank Hold → Sell
2023-08-04 Herabstufung TD Cowen Outperform → Market Perform
2023-08-03 Herabstufung Deutsche Bank Buy → Hold
2023-07-24 Eingeleitet William Blair Mkt Perform
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-06-26 Hochstufung UBS Neutral → Buy
2023-04-26 Eingeleitet Guggenheim Neutral
2023-03-13 Hochstufung TD Cowen Market Perform → Outperform
2023-03-02 Eingeleitet RBC Capital Mkts Outperform
2023-02-24 Herabstufung SVB Securities Market Perform → Underperform
2022-12-19 Hochstufung Jefferies Hold → Buy
2022-12-14 Herabstufung Chardan Capital Markets Buy → Neutral
2022-10-21 Hochstufung SVB Leerink Underperform → Mkt Perform
2022-09-08 Hochstufung Deutsche Bank Hold → Buy
2022-02-01 Hochstufung Redburn Sell → Neutral
2022-01-26 Hochstufung Deutsche Bank Sell → Hold
2022-01-21 Hochstufung BofA Securities Underperform → Neutral
2022-01-21 Eingeleitet UBS Neutral
2021-12-07 Eingeleitet Cowen Market Perform
2021-11-09 Eingeleitet Wolfe Research Outperform
2021-10-22 Eingeleitet Deutsche Bank Sell
2021-10-15 Hochstufung Piper Sandler Neutral → Overweight
2021-08-06 Herabstufung Oppenheimer Outperform → Perform
2021-08-06 Herabstufung Piper Sandler Overweight → Neutral
2021-07-15 Bestätigt Jefferies Hold
2021-02-01 Herabstufung BofA Securities Neutral → Underperform
2020-12-16 Herabstufung Jefferies Buy → Hold
2020-12-16 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-09 Herabstufung Needham Buy → Hold
2020-11-23 Eingeleitet Wells Fargo Equal Weight
2020-11-17 Herabstufung BMO Capital Markets Outperform → Market Perform
2020-09-08 Herabstufung SVB Leerink Mkt Perform → Underperform
2020-07-23 Eingeleitet SVB Leerink Mkt Perform
2020-07-20 Herabstufung JP Morgan Overweight → Neutral
2020-07-13 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Argus Buy
2020-06-08 Eingeleitet Barclays Overweight
2020-04-30 Eingeleitet BMO Capital Markets Outperform
2020-03-05 Herabstufung BofA/Merrill Buy → Neutral
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-25 Eingeleitet ROTH Capital Buy
2019-04-05 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Moderna Inc Aktie (MRNA) Neueste Nachrichten

pulisher
06:58 AM

Health and Human Service cancels funding to Moderna - The San Joaquin Valley Sun

06:58 AM
pulisher
04:03 AM

US CDC continues to recommend COVID vaccines for children, contradicts Kennedy - Reuters

04:03 AM
pulisher
02:17 AM

Moderna Bird Flu Vaccine Funding Canceled - Effingham Radio

02:17 AM
pulisher
01:39 AM

Two Sigma Advisers LP Sells 252,800 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

01:39 AM
pulisher
01:39 AM

US cancels $590 million contract with Moderna for bird flu shot - Watauga Democrat

01:39 AM
pulisher
11:43 AM

HHS pulls funding on bird flu vaccine for humans - MEAT+POULTRY

11:43 AM
pulisher
09:13 AM

HHS Cancels $590M Avian Flu Vax - Contract Pharma

09:13 AM
pulisher
06:53 AM

Lansforsakringar Fondforvaltning AB publ Invests $4.49 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

06:53 AM
pulisher
06:38 AM

HHS cancels Moderna’s $590 million contract for bird flu vaccine - Ponca City News

06:38 AM
pulisher
03:29 AM

Trump administration cancels $766 million Moderna contract to fight pandemic flu - The Lawton Constitution

03:29 AM
pulisher
May 29, 2025

Moderna, Inc. (NASDAQ:MRNA) Holdings Reduced by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Lazard Asset Management LLC Sells 11,516 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Trump administration pulls bird flu, other vaccine funding awarded to Moderna - CBS News

May 29, 2025
pulisher
May 29, 2025

HHS cancels Moderna bird flu vaccine contract - The Iola Register

May 29, 2025
pulisher
May 29, 2025

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine - The New York Times

May 29, 2025
pulisher
May 29, 2025

HHS cancels $766m bird flu vaccine contract with Moderna - Pharmaceutical Technology

May 29, 2025
pulisher
May 29, 2025

Moderna at Bernstein Conference: Strategic Diversification Plans - Investing.com

May 29, 2025
pulisher
May 29, 2025

Is Moderna Stock A Sell After RFK Jr. Yanks Its Bird Flu Vaccine Funding? - Investor's Business Daily

May 29, 2025
pulisher
May 29, 2025

HHS terminates Moderna contract to develop bird flu vaccine - BioPharma Dive

May 29, 2025
pulisher
May 29, 2025

US cancels more than $700 million funding for Moderna bird flu vaccine - Reuters

May 29, 2025
pulisher
May 29, 2025

HHS terminates Moderna’s funding for bird flu vaccine, calls mRNA 'under-tested' - The Business Journals

May 29, 2025
pulisher
May 29, 2025

Transcript : Moderna, Inc. Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 10 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash. - Barron's

May 29, 2025
pulisher
May 29, 2025

Trump administration cancels $766 million Moderna contract to fight future pandemics, including bird flu - NBC News

May 29, 2025
pulisher
May 29, 2025

U.S. Ends $600M Moderna Bird Flu Vaccine Contract - HomeTown Register

May 29, 2025
pulisher
May 29, 2025

HHS cancels $590 million contract with Moderna for bird flu vaccine - WYFF

May 29, 2025
pulisher
May 29, 2025

HHS, led by vaccine skeptic RFK Jr., cancels contract to fight flu viruses - LiveNOW from FOX

May 29, 2025
pulisher
May 29, 2025

Moderna: positive results for H5 avian influenza vaccine - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Moderna (MRNA) Faces Uncertainty After $766M Contract Termination - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Trump administration cancels $766 million contract with Moderna to develop vaccine against pandemic flu viruses - Fortune

May 29, 2025
pulisher
May 29, 2025

U.S. cancels Moderna bird flu vaccine contract amid mRNA reevaluation - Farm Progress

May 29, 2025
pulisher
May 29, 2025

Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount - BioSpace

May 29, 2025
pulisher
May 29, 2025

Big blow to Moderna vaccine projects as Trump cancels over $700 million funding - The Economic Times

May 29, 2025
pulisher
May 29, 2025

Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results - CBS News

May 29, 2025
pulisher
May 29, 2025

Moderna stock steady as HHS ends vaccine contract (MRNA:NASDAQ) - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Trump Team Pulls $766M Funding Plug on Moderna’s Bird Flu Vaccine - TipRanks

May 29, 2025
pulisher
May 29, 2025

Moderna’s H5 avian flu vaccine shows promise in early trial By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

US cancels $766 million pandemic flu vaccine support to Moderna - India Today

May 29, 2025
pulisher
May 29, 2025

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort - Benzinga

May 29, 2025
pulisher
May 29, 2025

Trump admin cancels $766m Moderna contract to fight pandemic flu - MSN

May 29, 2025
pulisher
May 29, 2025

US cancels $700m in funding for Moderna's bird flu vaccine - The Express Tribune

May 29, 2025
pulisher
May 29, 2025

Moderna Says Investigational Influenza Vaccine Boosts Immunity; US Government to Terminate Funding - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Blue Sky Capital Consultants Group Inc. Purchases Shares of 14,563 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Woodline Partners LP Purchases 10,968 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 29, 2025
pulisher
May 29, 2025

U.S. Government cancels $766 million Moderna contract to fight pandemic flu - The Hindu

May 29, 2025
pulisher
May 29, 2025

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Moderna Stock Drops On HHS Funding Termination For Pandemic Flu Vaccine; Retail Turns Bearish By Stocktwits - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Trump administration cancels $766 million contract to develop mRNA-based flu vaccines - FOX 13 News Utah

May 28, 2025
pulisher
May 28, 2025

Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects - Times of India

May 28, 2025
pulisher
May 28, 2025

Trump's HHS cancels Moderna's $590M bird flu vaccine award - Axios

May 28, 2025

Finanzdaten der Moderna Inc-Aktie (MRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):